Biochemical characterisation of Troponin C mutations causing hypertrophic and dilated cardiomyopathies

Athanasia Kalyva1, Fragiskos I Parthenakis, Maria E Marketou

  • 1Molecular Cardiology Laboratory, Department of Cardiology, School of Medicine, University of Crete, Crete, Greece, natasa.kalyva@gmail.com.

Insights

Mutations in cardiac troponin C (TnC) cause cardiomyopathies. HCM mutations increase Ca(2+) sensitivity, while DCM mutations decrease it and impair responses to phosphorylation.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Sarcomere Function

Background:

  • Cardiac muscle contraction relies on actin-myosin interactions regulated by the troponin complex and calcium (Ca2+).
  • Genetic mutations in sarcomeric proteins are primary causes of familial hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).

Purpose of the Study:

  • To review in vitro studies characterizing six HCM and six DCM mutations in the cardiac troponin C (TnC) gene.
  • To elucidate how these TnC mutations contribute to cardiac dysfunction.

Main Methods:

  • In vitro characterization of six HCM and six DCM mutations in the cardiac TnC gene.
  • Analysis of Ca2+ binding affinities and interactions with binding partners for mutant TnC proteins.

Main Results:

  • HCM mutations in TnC significantly increase Ca2+ sensitivity of force development and ATPase activity compared to wild-type (WT) TnC.
  • DCM mutations in TnC tend to decrease Ca2+ sensitivity of force development and ATPase activity compared to WT TnC.
  • DCM TnC mutants show unresponsiveness to TnI phosphorylation, maintaining Ca2+ sensitivity, unlike WT filaments.

Conclusions:

  • Cardiac TnC mutations differentially impact Ca2+ sensitivity, explaining their roles in HCM and DCM.
  • Altered Ca2+ binding and disrupted regulatory signaling pathways due to TnC mutations lead to cardiomyopathies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645